EUVIMEDEUVIMED entdecken
Open Access

Predictors of corporo-venocclusive dysfunction in men with bilateral nerve-sparing radical prostatectomy

Jose M Flores, Luis F Novaes iD, Emily Vertosick, Carolyn Salter iD, Nicole Liso, Andrew J Vickers, John P Mulhall, Fecsm

The Journal of Sexual Medicine · 2025

DOI: 10.1093/jsxmed/qdae157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Sexual Medicine, 2025. Verfasst von Jose M Flores und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sexual & Reproductive Medicine Program, Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United St…. Hauptthemen laut MEDLINE: Prostatectomy, Penis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Patient-Centered Outcomes Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Erectile dysfunction (ED) is seen in some men who have undergone bilateral nerve-sparing surgery. Corporo-venocclusive dysfunction (CVOD) is the major pathway to permanent ED after radical prostatectomy (RP).

Aim

To identify comorbidity factors that are associated with the presence of CVOD in men who had undergone bilateral nerve-sparing RP.

Methods

We included patients who had no ED before RP, underwent bilateral nerve-sparing RP, were unresponsive to pharmacotherapy, and had a penile Duplex Doppler Ultrasound (PDDU) with a diagnosis of CVOD. PDDU was performed with a redosing vasoactive agent protocol. A logistic regression model was created to define predictors of CVOD, defined as end-diastolic velocity (EDV) ≥ 5 cm/s bilaterally. Outcomes CVOD diagnosis.

Results

135 patients with a median age of 60 (IQR 54, 64) years were included. 45% reported ≥2 comorbidities, 10% diabetes, 28% obstructive sleep apnea (OSA), and 44% were current or former smokers. At PDDU, 34% had less than penetration hardness erections, and 43% received 100 units of vasoactive agent. 44% were diagnosed with CVOD. Increased age at RP (OR 2.12 per 10 years, 95% CI 2.35, 3.73, P = .007) and OSA (OR 2.44, 95% CI 1.07, 5.73, P = .036) were associated with a diagnosis of CVOD. Clinical implications Comorbidities, especially OSA, have a role in erection recovery after surgery. Strengths and limitations The study used a well-established institutional RP nerve-sparing score, a strict PDDU vasoactive agent redosing protocol, validated cut-offs for CVOD diagnosis, and a validated erectile function questionnaire both pre- and post-operatively. The major limitation is that this is a cohort of men seeking treatment at a sexual medicine clinic for post-operative ED, which limits the generalizability of the results to patients without ED symptoms or who decided not to seek treatment. The dichotomous definition of comorbidities is also a limitation since patients can have differing degrees of comorbidities’ severity.

Conclusion

Older patients and the presence of OSA were associated with the presence of CVOD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyPenisHumansMaleMiddle AgedErectile DysfunctionUltrasonography, Doppler, DuplexComorbidityPostoperative ComplicationsSleep Apnea, ObstructiveImpotence, VasculogenicRisk FactorsOrgan Sparing TreatmentsProstatic Neoplasms

Stichwörter der Autor:innen

erectile dysfunctionpenile duplex doppler ultrasoundradical prostatectomysleep apnea

Autor:innen und Institutionen

  • Sexual & Reproductive Medicine Program, Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
  • Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

ORCID-Profile: Luis F Novaes, Carolyn Salter

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Patient-Centered Outcomes Research Institute
  • Prostate Cancer Foundation
  • Sidney Kimmel Center for Prostate and Urologic Cancers
  • National Institutes of Health
  • National Cancer Institute
  • Memorial Sloan Kettering Cancer Center

Zitieren

APA

Flores, J. M., Novaes, L. F., Vertosick, E., Salter, C., Liso, N., Vickers, A. J., Mulhall, J. P., & Fecsm (2025). Predictors of corporo-venocclusive dysfunction in men with bilateral nerve-sparing radical prostatectomy. The Journal of Sexual Medicine. https://doi.org/10.1093/jsxmed/qdae157

Vancouver

Flores JM, Novaes LF, Vertosick E, Salter C, Liso N, Vickers AJ, et al. Predictors of corporo-venocclusive dysfunction in men with bilateral nerve-sparing radical prostatectomy. The Journal of Sexual Medicine. 2025. doi:10.1093/jsxmed/qdae157

BibTeX
@article{Flores2025,
  author = {Flores, Jose M and Novaes, Luis F and Vertosick, Emily and Salter, Carolyn and Liso, Nicole and Vickers, Andrew J and Mulhall, John P and Fecsm},
  title = {Predictors of corporo-venocclusive dysfunction in men with bilateral nerve-sparing radical prostatectomy},
  journal = {The Journal of Sexual Medicine},
  year = {2025},
  doi = {10.1093/jsxmed/qdae157}
}
Kostenlos starten →